AGT and hypertensive disorder: Another phase 2 study with 26 participants with treatment-resistant hypertension receiving 2–3 antihypertensive medications showed a significant 67% AGT reduction by day 57 in those receiving 80 mg weekly IONIS-AGT-LRx doses (nine doses in total).